Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy is a research paper published in The Journal of Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 48 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Thyroid Association
Grant: THYROIDGRANT2020-0000000169
HHS | National Institutes of Health
Grant: K08 DK129829
NIDDK NIH HHS
Grant: R01 DK119445
NCI NIH HHS
Grant: R35 CA197633
NIAID NIH HHS
Grant: T32 AI007323
NCI NIH HHS
Grant: P30 CA016042
NCI NIH HHS
Grant: R01 CA236910
Aramont Charitable Foundation
Parker Institute for Cancer Immunotherapy
FWCI
3.91
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals